Revive Therapeutics Update Following U.S. FDA Approval of Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, Aug. 05, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty […]
Algernon Announces First Patient Dosed in Phase 2 IPF and Chronic Cough Human Trial of Ifenprodil
VANCOUVER, British Columbia, Aug. 05, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or […]
NexTech AR Solutions to Webcast Live at VirtualInvestorConferences.com August 6th
VANCOUVER, British Columbia, Aug. 05, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an […]
Acreage Announces Upcoming Conference Presentations
NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE: ACRG.U) (OTCQX: ACRGF) (FSE: […]
BetterLife Announces Trading Halt Following Merger with Altum
Vancouver, Aug. 05, 2020 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / […]
i3 Interactive and the Incredible Dan Bilzerian Effect
TORONTO, Aug. 05, 2020 (GLOBE NEWSWIRE) — i3 Interactive Inc. (“i3 Interactive” or the “Company”) (CSE: BETS)(FRA: F0O3) is pleased […]
CB2 Insights Technology Platform Selected by Dharma Pharmaceuticals to Study Real-World Health Outcomes
Dharma will license the Company’s proprietary technology platform “Sail” to use at the point of care within Dharma dispensaries and […]
Eurogas International Inc. Announces 2020 Second Quarter Financial Results
TORONTO, Aug. 04, 2020 (GLOBE NEWSWIRE) — Eurogas International Inc. (CSE: EI) (“Eurogas International” or the “Corporation”) today announced its […]
i3 Interactive Commences Trading on Frankfurt Stock Exchange
TORONTO, Aug. 04, 2020 (GLOBE NEWSWIRE) — i3 Interactive Inc. (“i3 Interactive” or the “Company”) (CSE: BETS) (FRA: F0O3) is […]
XORTX Partners with Mount Sinai’s Icahn School of Medicine on US-based Clinical Trial in COVID-19
CALGARY, Alberta, Aug. 04, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a […]
